ARCHIVES

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: McDonnell Foundation Selects Five For Awards; James Benson Is Named Interim FDA Head

November 24, 1989

Senate Committee Proposes $100 Million DOD Prostate Cancer Research Program

July 12, 1996

ACS Offers New Grants to Physicians

September 7, 1984

Letters to The Editors: Donald Coffey Finds Sensationalism Hurts

June 6, 1997

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

June 28, 2013

Funding Opportunities: NIH Creates Awards For Clinical Research

March 27, 1998